Assyro AI

Orange Book product · Brand (NDA)

DORAL

QUAZEPAM

Brand (NDA)NDA 018708RX GALT PHARMS

At a glance

Dec 27, 1985

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 27, 1985

    41 yr 1 mo ago

  2. Today

  3. Patent 7608616 expires

    Listed method-of-use patent (U-1012) expiration.

    Jun 03, 2028

    in 2 yr

Pharmaceutical detail

Active ingredient

QUAZEPAM

Strength

15MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 018708

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7608616Jun 03, 2028in 2 yr
U-1012
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.